Obesity
An Experimental GLP-1 Pill Delivered Up to 12% Weight Loss in a Mid-Stage Trial
Structure Therapeutics’ once-daily oral drug aleniglipron cut body weight by 12.1% over 36 weeks — a convenient, needle-free take on the blockbuster GLP-1 class.